Opthea Ltd has released a press release.
Opthea Half Year Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Opthea
- Angiogenesis 2022 -Prof Cheung presentation of PCV data
- Opthea announces establishment of ATM Equity Program
- Opthea Receives A$6.6m R&D Tax Incentive
- Opthea Granted Chinese Patent Covering OPT-302
- Opthea opens patient enrollment in the Asia-Pacifi Region
Later from Opthea
- S&P DJI Announces March 2022 Quarterly Rebalance
- Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
- Opthea Data for OPT-302 for PCV presented at ARVO 2022
- Opthea secures up to US$170m in non-dilutive financing
- Opthea Successfully Closes Well Supported US$90m Financing
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea